The efficacy of intra-tracheal budesonide with surfactant in treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia
Background: Premature birth is an important issue in developed and developing countries. Surfactant replacement therapy of respiratory distress syndrome (RDS) causes a change in the normal pattern of the disease and increases the likelihood of survival of more premature newborns with chronic pulmona...
Main Authors: | Manizheh Mostafa Gharehbaghi, Shalale Ganji, Majid Mahallei |
---|---|
Format: | Article |
Language: | fas |
Published: |
Tabriz University of Medical Sciences
2021-04-01
|
Series: | مجله پزشکی دانشگاه علوم پزشکی تبریز |
Subjects: | |
Online Access: | https://mj.tbzmed.ac.ir/PDF/mj-43-1-48.pdf |
Similar Items
-
A Randomized Clinical Trial of Intratracheal Administration of Surfactant and Budesonide Combination in Comparison to Surfactant for Prevention of Bronchopulmonary Dysplasia
by: Manizheh M. Gharehbaghi, et al.
Published: (2021-07-01) -
Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration
by: Chung-Ming Chen, et al.
Published: (2019-01-01) -
The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial
by: Asghar Marzban, et al.
Published: (2024-04-01) -
Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
by: Morteza Habibi, et al.
Published: (2024-01-01) -
Surfactant-Assisted Distal Pulmonary Distribution of Budesonide Revealed by Mass Spectrometry Imaging
by: Riccardo Zecchi, et al.
Published: (2021-06-01)